Does a Lower Stock Price and New Contracts Make SpaceX Stock a Buy?

SpaceX stock has fallen 23% from its peak and is now back below its IPO-day closing price, despite recent contract wins that add $2.32 billion per month in new backlog. The three deals with Anthropic, Alphabet, and Reflection AI imply $27.84 billion of annualized revenue and lift 2026 revenue estimates to about $46.5 billion, but the stock still trades at roughly 44x forward sales. The article argues the valuation remains elevated and suggests any bullish position should be small.

Analysis

The market is still treating this as a scarcity asset, but the math is starting to resemble a late-cycle private-market cap table rather than a growth stock. The new backlog helps near-term revenue visibility, yet it also makes the base case more dependent on flawless contract conversion and capacity execution over the next 24-36 months; any slippage would hit both the multiple and the narrative at the same time. The more interesting second-order effect is that these large compute commitments can crowd out smaller customers and create concentration risk, which investors are likely underpricing.

GOOGL is the cleanest fundamental beneficiary if the infrastructure access is accretive to its AI stack without forcing it into permanent overcommitment on cost. NVDA benefits from the same dynamic because every incremental multi-year GPU reservation supports utilization, pricing power, and the perception of persistent scarcity, but that also embeds a longer-duration demand illusion that can reverse if hyperscalers pause capex. The relative loser is PLTR, not on direct competition, but because a premier AI-adjacent asset trading at extreme sales multiples weakens the justification for paying even higher multiples elsewhere in software.

The contrarian issue is that the market is extrapolating contract value into equity value too mechanically. These deals improve forward visibility, but they do not eliminate financing, delivery, and margin risk; if gross margin on compute remains compressed or capex intensity spikes, the implied 44x forward sales can de-rate fast. Over the next 1-3 months, the stock is vulnerable to any indication that initial enthusiasm was driven by flow rather than fundamentals; over 6-12 months, the key catalyst is whether booked backlog converts into durable free cash flow rather than headline revenue.

Key Decisions for Investors

• Avoid initiating long exposure in the IPO name here; if held, trim 25-50% on strength and only consider re-entry after a 15-20% de-rating or evidence of margin inflection over the next 1-2 quarters.
• Long GOOGL / short the IPO name as a relative-value pair for 3-6 months: own the platform that monetizes AI demand with lower execution risk, short the asset with the highest narrative-to-fundamental gap.
• Stay constructive on NVDA on pullbacks, but size it as a quality compounder rather than a momentum chase; use 6-12 month horizon and only add if GPU order visibility remains firm into the next capex season.
• Underweight PLTR on valuation dispersion grounds for the next quarter; the setup worsens if the market continues to reward AI adjacency over cash conversion, making it a better short candidate on rips than on dips.